Linked Life Data

983742

Source:http://linkedlifedata.com/resource/pubmed/id/983742

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1977-1-3
pubmed:abstractText
The effect of Nomifensin (Hoechst 36984), a new psychotropic agent different from tricyclics and MAO inhibitors, was studied in patients with depressive-anxiety syndromes. Thirty three patients (22 female, 11 male), average age 40 years, were studied for five weeks in an open trial. The educational and occupational levels of the samples were determined. Follow-up was carried out with Wittenborn Psychiatric Rating Scale, Hamilton Rating Scale for Depression, Zung Self-Rating Scale and PEN Personality Inventory. No other drug was allowed to be taken along with Nomifensin, except for a benzodiazepine derivate in case of disturbed sleep. The average dose was 67 mg/day. The changes in Hamilton and Zung Scales were statistically significant, after the first week of treatment with Nomifensin. Only the N Scale of the PEN showed a a before/after treatment significant difference. The r=0.63 correlation obtained between Zung and Hamilton Scales is discussed. The drug showed to have thymoleptic action within the first week of treatment and an additional on the anxiety symptoms, frequently associated to reactive depressions.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0001-6896
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
133-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1976
pubmed:articleTitle
[Treatment of depressive and anxiety neurosis with a new psychotropic drug: Nomifensin].
pubmed:publicationType
Journal Article, English Abstract